These results collectively indicate that CCL2 in the metastatic tumor microenvironment triggers a chemokine cascade involving CCL3-CCR1 signaling that promotes retention of MAMs in the metastatic lung (Figure 3A). The gene discussed is CCL2; the disease is neoplasm.